Cockram C S, Jones R H, Boroujerdi M A, Sönksen P H
Diabetes. 1984 Aug;33(8):721-7. doi: 10.2337/diab.33.8.721.
To compare the metabolic characteristics and degradation of insulin tracers labeled unselectively, selectively at the A14 position (A14-monoiodoinsulin), and selectively at the B1 position (B1-monoiodoinsulin), we have followed the time course of disappearance of intact (immunoprecipitable [IP] and trichloroacetic acid [TCA] precipitable) iodoinsulin after bolus injection into greyhounds. We have used noncompartmental analysis to determine metabolic clearance rate (MCR) and apparent distribution space (DS). We have also measured the appearance of non-IP- and non-TCA-precipitable fragments, and have developed a mathematical model using compartmental analysis to explain the observed differences. B1-Monoiodoinsulin has a significantly higher MCR (16.3 ml/min/kg) than both A14-monoiodoinsulin (10.6 ml/min/kg) and unfractionated tracers (7.6 ml/min/kg) as determined by immunoprecipitation, and reaches the values observed for native insulin in greyhounds. MCR values obtained by TCA precipitation are approximately one-half of those obtained by IP for all 3 tracers. The concentration of non-IP fragments is significantly lower with B1-monoiodoinsulin than with the other tracers. Compartmental analysis suggests this to be due to greater intracellular retention of the B1 moiety during the experimental period. We conclude that: (1) by the criterion of MCR, B1-monoiodoinsulin seems to behave more like native insulin than other preparations tested; (2) the reduced MCR of A14-monoiodoinsulin raises doubts about its validity as a tracer for insulin; (3) a high-molecular-weight product of insulin degradation, which includes both the B1 and the A14-A19 regions of the molecule, is released into the circulation; and (4) smaller fragments containing A14-A19 reappear in the circulation more rapidly than fragments containing B1.(ABSTRACT TRUNCATED AT 250 WORDS)
为比较未选择性标记、在A14位选择性标记(A14 - 单碘胰岛素)以及在B1位选择性标记(B1 - 单碘胰岛素)的胰岛素示踪剂的代谢特征和降解情况,我们追踪了在灵缇犬静脉注射大剂量碘胰岛素后完整的(免疫沉淀[IP]和三氯乙酸[TCA]沉淀)碘胰岛素消失的时间进程。我们采用非房室分析来确定代谢清除率(MCR)和表观分布容积(DS)。我们还测量了非IP和非TCA沉淀片段的出现情况,并利用房室分析建立了一个数学模型来解释观察到的差异。通过免疫沉淀测定,B1 - 单碘胰岛素的MCR(16.3毫升/分钟/千克)显著高于A14 - 单碘胰岛素(10.6毫升/分钟/千克)和未分级示踪剂(7.6毫升/分钟/千克),并达到了灵缇犬体内天然胰岛素的MCR值。对于所有3种示踪剂,通过TCA沉淀获得的MCR值约为通过IP获得值的一半。B1 - 单碘胰岛素的非IP片段浓度显著低于其他示踪剂。房室分析表明,这是由于在实验期间B1部分在细胞内的保留更多。我们得出以下结论:(1)以MCR为标准,B1 - 单碘胰岛素似乎比其他测试制剂更类似于天然胰岛素;(2)A14 - 单碘胰岛素降低的MCR对其作为胰岛素示踪剂的有效性提出了质疑;(3)胰岛素降解的一种高分子量产物,包括分子的B1和A14 - A19区域,被释放到循环中;(4)含有A14 - A19的较小片段比含有B1的片段更快地重新出现在循环中。(摘要截短于250字)